Follow-up Protocol for Negative Initial Hepatitis and HIV Tests After Laceration Exposure
After an initial negative hepatitis panel and HIV test following a laceration exposure, follow-up testing should include HIV antibody testing at 6 weeks, 3 months, and 6 months post-exposure, and hepatitis C testing at 4-6 months post-exposure. 1, 2
Testing Schedule for HIV
The follow-up protocol for HIV exposure requires a systematic approach:
- Baseline: Initial negative test (already completed)
- 6 weeks post-exposure: HIV antibody testing
- 3 months post-exposure: HIV antibody testing
- 6 months post-exposure: Final HIV antibody testing 1
Additional HIV testing should be performed immediately if any symptoms compatible with acute retroviral syndrome develop during the follow-up period. These may include fever, lymphadenopathy, rash, myalgia, and pharyngitis. 1, 2
Testing Schedule for Hepatitis
For hepatitis follow-up, the protocol differs by virus type:
Hepatitis B (HBV)
- If hepatitis B vaccine was administered after exposure, test for anti-HBs 1-2 months after the last vaccine dose
- Note: If hepatitis B immunoglobulin (HBIG) was received, anti-HBs response cannot be accurately assessed for 3-4 months 1
Hepatitis C (HCV)
- 4-6 months post-exposure: Follow-up testing for anti-HCV and alanine aminotransferase (ALT)
- Optional earlier testing: HCV RNA at 3-6 weeks if earlier diagnosis is desired 1, 3
- Any repeatedly reactive anti-HCV enzyme immunoassays should be confirmed with supplemental tests 1
Precautions During Follow-up Period
During the entire follow-up period, advise the exposed person to:
- Use precautions to prevent potential secondary transmission
- Seek immediate medical evaluation for any acute illness occurring during follow-up
- Avoid blood/organ donation during the follow-up period 1, 2
Special Considerations
- If the source patient's status was unknown or positive, the follow-up protocol remains the same, but adherence to the full testing schedule becomes even more critical 1
- The risk of HIV infection from a single exposure is relatively low (0.3%), but complete follow-up testing is essential to confirm absence of infection 4
- For healthcare workers, these exposures should be documented and reported according to institutional protocols to ensure proper follow-up 1, 2
Common Pitfalls to Avoid
- Incomplete follow-up: Many exposed individuals fail to complete the full testing schedule. Healthcare facilities should develop systems to encourage return for follow-up testing 1
- Premature termination of monitoring: Even with initial negative results, the full monitoring period must be completed to ensure no seroconversion occurs
- Failure to recognize symptoms: Acute retroviral syndrome may be mistaken for other viral illnesses, so any compatible symptoms should prompt immediate testing 1, 2